Researchers have developed a machine learning-based gene signature, NPC-RSS, to predict which nasopharyngeal cancer patients will benefit from radiotherapy.
Key Details
- 1A team at Southern Medical University created the NPC-RSS model using transcriptomic data from NPC patients.
- 2The model uses an 18-gene signature and was refined using 113 machine learning algorithm combinations.
- 3NPC-RSS demonstrated strong predictive accuracy in both internal and external validation datasets.
- 4Radiosensitive tumors showed richer immune cell activity, suggesting immune dynamics play a role in radiotherapy response.
- 5The tool aims to guide personalized radiotherapy decisions and reduce unnecessary treatment exposure.
- 6Further sample collection and international validation are ongoing to refine the model.
Why It Matters
Personalized radiotherapy guided by AI can improve outcomes in nasopharyngeal cancer by identifying patients most likely to benefit, addressing the challenge of radiation resistance. This tool could help clinicians tailor therapies, limit overtreatment, and improve patient survival.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
•EurekAlert
AI Model Uses EKG and EHR Data to Predict Sudden Cardiac Arrest
Researchers have developed AI models that analyze EKG and EHR data to predict risk of sudden cardiac arrest in the general population.